184 related articles for article (PubMed ID: 28038473)
1. Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.
Boldrup L; Gu X; Coates PJ; Norberg-Spaak L; Fahraeus R; Laurell G; Wilms T; Nylander K
Oncotarget; 2017 Mar; 8(12):19389-19402. PubMed ID: 28038473
[TBL] [Abstract][Full Text] [Related]
2. Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma.
Chen HC; Yang CM; Cheng JT; Tsai KW; Fu TY; Liou HH; Tseng HH; Lee JH; Li GC; Wang JS; Hou YY; Weng TJ; Ger LP
J Oral Pathol Med; 2016 Jul; 45(6):409-17. PubMed ID: 26525607
[TBL] [Abstract][Full Text] [Related]
3. Potential markers of tongue tumor progression selected by cDNA microarray.
Carinci F; Lo Muzio L; Piattelli A; Rubini C; Chiesa F; Ionna F; Palmieri A; Maiorano E; Pastore A; Laino G; Dolci M; Pezzetti F
Int J Immunopathol Pharmacol; 2005; 18(3):513-24. PubMed ID: 16164832
[TBL] [Abstract][Full Text] [Related]
4. Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas.
Högmo A; Kuylenstierna R; Lindholm J; Nathansson A; Auer G; Munck-Wikland E
Mol Pathol; 1998 Oct; 51(5):268-72. PubMed ID: 10193521
[TBL] [Abstract][Full Text] [Related]
5. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis.
Ke ZF; He S; Li S; Luo D; Feng C; Zhou W
Cancer Epidemiol; 2013 Apr; 37(2):179-85. PubMed ID: 23142337
[TBL] [Abstract][Full Text] [Related]
6. MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer.
Yang X; Wu K; Li S; Hu L; Han J; Zhu D; Tian X; Liu W; Tian Z; Zhong L; Yan M; Zhang C; Zhang Z
Oncotarget; 2017 Jan; 8(2):2525-2535. PubMed ID: 27713166
[TBL] [Abstract][Full Text] [Related]
7. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
8. Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue?
Davies L; Hardin NJ; Beatty BG
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):12-7. PubMed ID: 16466094
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival.
Attaran N; Gu X; Coates PJ; Fåhraeus R; Boldrup L; Wilms T; Wang L; Sgaramella N; Zborayova K; Nylander K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867395
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma.
Boldrup L; Coates PJ; Laurell G; Wilms T; Fahraeus R; Nylander K
Br J Cancer; 2015 May; 112(11):1760-5. PubMed ID: 25965165
[TBL] [Abstract][Full Text] [Related]
11. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.
Kauppila JH; Mattila AE; Karttunen TJ; Salo T
Br J Cancer; 2013 Feb; 108(3):638-43. PubMed ID: 23287987
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
14. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
[TBL] [Abstract][Full Text] [Related]
15. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
16. Loss of Fhit expression is a predictor of poor outcome in tongue cancer.
Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L
Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL overexpression and its association with the progress of tongue carcinoma.
Zhang K; Jiao K; Xing Z; Zhang L; Yang J; Xie X; Yang L
Int J Clin Exp Pathol; 2014; 7(11):7360-77. PubMed ID: 25550772
[TBL] [Abstract][Full Text] [Related]
18. TUNEL as a tumor marker of tongue cancer.
Ben-Izhak O; Laster Z; Akrish S; Cohen G; Nagler RM
Anticancer Res; 2008; 28(5B):2981-6. PubMed ID: 19031943
[TBL] [Abstract][Full Text] [Related]
19. Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Ernst J; Ikenberg K; Apel B; Schumann DM; Huber G; Studer G; Rordorf T; Riesterer O; Rössle M; Korol D; Bredell MG
Oncotarget; 2016 Nov; 7(46):76151-76158. PubMed ID: 27764819
[TBL] [Abstract][Full Text] [Related]
20. P21WAF1/CIP1 protein and tongue cancer prognosis.
Gonzalez-Moles MA; Ruiz-Avila I; Martinez JA; Gil-Montoya JA; Esteban F; Gonzalez-Moles S; Bravo-Perez M; Bascones A
Anticancer Res; 2004; 24(5B):3225-31. PubMed ID: 15510615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
